Scott Braunstein
2021 - MARINUS PHARMACEUTICALS
In 2021, Scott Braunstein earned a total compensation of $4M as President, Chief Executive Officer and Director at MARINUS PHARMACEUTICALS, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,345 |
|---|---|
| Option Awards | $3,123,300 |
| Salary | $574,000 |
| Other | $26,684 |
| Total | $3,992,329 |
Braunstein received $3.1M in option awards, accounting for 78% of the total pay in 2021.
Braunstein also received $268.3K in non-equity incentive plan, $574K in salary and $26.7K in other compensation.
Rankings
In 2021, Scott Braunstein's compensation ranked 3,355th out of 12,415 executives tracked by ExecPay. In other words, Braunstein earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,355 out of 12,415 | 73rd |
Division Manufacturing | 1,363 out of 5,508 | 75th |
Major group Chemicals And Allied Products | 556 out of 2,378 | 77th |
Industry group Drugs | 495 out of 2,099 | 76th |
Industry Pharmaceutical Preparations | 343 out of 1,549 | 78th |
Source: SEC filing on April 11, 2022.
Braunstein's colleagues
We found two more compensation records of executives who worked with Scott Braunstein at MARINUS PHARMACEUTICALS in 2021.